Literature DB >> 34394239

Effects of body weight and posture on pulmonary functions in asthmatic children.

Ghobrial Emad Emil1, El Baz Mohamed Saad1, Abdel Fattah Mohammed1, Haroun Manar Mohamed2.   

Abstract

BACKGROUND: Asthma is one of the most common chronic illnesses in the world. Pulmonary function tests are important tools in monitoring of asthmatic patients. There is need for investigating if spirometric indices were affected by body weight or posture or not.
OBJECTIVES: The aim of this study was to evaluate the spirometric measurements in standing and sitting positions in a group of Egyptian asthmatic children with different body weights.
METHODS: Sixty patients were included. They were stable asthmatics and were following up in the allergy clinic. Spirometry was conducted at pulmonary functions laboratory of Pediatric Allergy and Chest Unit of New Children's University Hospital, Cairo. The one-way analysis of variance was used to test the differences between groups. The Duncan multiple comparison test was used to test the significant differences between each pair of groups.
RESULTS: The study found that sitting FEV1/FVC is significantly lower in overweight/obese asthmatic children compared to normal weight asthmatic children (p value=0.046).
CONCLUSION: There was no effect of weight on standing spirometric data. Weight showed significant negative correlation with asthma control level. We concluded that in overweight/obese asthmatic children, spirometric position might affect the results.
© 2020 Emil GE et al.

Entities:  

Keywords:  Body weight; asthmatic children; posture

Mesh:

Year:  2020        PMID: 34394239      PMCID: PMC8351838          DOI: 10.4314/ahs.v20i4.31

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


Introduction

Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness, and cough that vary over time and in intensity, together with variable expiratory airflow limitation1. Asthma severity can be assessed when the patient has been on regular controller treatment for several months2. The simultaneous increment in the prevalence of obesity and allergic diseases suggests a possible link between them. Obesity is related more strongly to non-atopic than atopic asthma, and the mechanisms of asthma in obese patients could involve mechanical effects of obesity on lung function, adipokines-mediated inflammation, environmental factors and co-morbidities3. In obese individuals, sitting position might interfere with descent of diaphragm and it is possible that this effect will be reduced by standing position4. Pulmonary function tests (PFTS) are an important tool in the investigation and monitoring of patients with respiratory pathology. They provide important information relating to the large and small airways and the pulmonary parenchyma. Spirometry is the most frequently used measurement of lung function and is a measurement of volume against time. It is a simple and quick procedure to perform. Measurements that are made include: Forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and the ratio of the two volumes (FEV1/FVC). Calculation of FEV1/FVC allows the identification of obstructive or restrictive ventilatory defects5. The FEV1/FVC ratio is the most sensitive and specific indicator for identifying airway obstruction. These parameters are compared with reference values. References values have been published for different countries6. Pulmonary functions should be assessed at diagnosis or start of treatment; after 3–6 months of controller treatment to assess the patient's personal best forced expiratory volume in 1 second (FEV1) and periodically thereafter1. American Thoracic Society (ATS) and European Respiratory Society (ERS) recommended performing spirometry in sitting position7. Children have a dynamic developmental phase during which lung volume size and airway size change with increasing age. Spirometry parameters are influenced by weight, height, age, sex, environmental factors, ethnicity, prematurity, patient cooperation and effort and technical factors8. Solid information on the effects of position and body weight on forced expiratory manoeuvres in children is still lacking. Thus there is need for investigating if spirometric indices (forced expiratory volume in first second [FEV1], forced vital capacity [FEV], forced expiratory flow after 50% of FVC [FEF 50] and peak expiratory flow [PEF]) were affected by body weight or testing posture or not9. The aim of this study was to evaluate the spirometric measurements in standing and sitting positions in a group of Egyptian asthmatic children with different body mass index (BMI) [(normal weight, overweight and obese].

Methods

This cross-sectional study was conducted at University Children's' Hospital, Faculty of Medicine, Cairo University, Egypt. Sixty patients were included. They were stable asthmatics diagnosed according to Global Initiative for Asthma guidelines (GINA, 2015)1 and were following-up in the chest allergy clinic of the hospital. The study was conducted from August 2015 to January 2016. Sixty consecutive patients regularly following in the chest allergy clinic of Children's' Hospital, Cairo University were assigned to participate in this study. This clinic is a specialized clinic in our tertiary hospital, which received patients referred from the general out-patients' clinics and from outside the hospital. Sample size calculation was performed using Power and Sample Size Calculator program version 3.0.43. It was based on the following inputs: Power of 80 %, Type I error of 0.05, and within-group standard deviation of 0.2. They were divided into 3 subgroups based on their body mass index (BMI = weight in kilograms divided by squared height in meters) using the international cutoff points for overweight and obese children published by Cole et al., (2000)10; subgroup 1: included asthmatic children with normal body weight; subgroup 2: included overweight asthmatic children and subgroup 3: included obese asthmatic children. Patients aged from 6 years to 16 years with a diagnosis of asthma (according to GINA guidelines), not receiving bronchodilators before study enrollment were included in the study. Underweight children (weight below 5th percentile for age) and acute asthmatic children were excluded from the study. Both underweight and children with exacerbation may have concomitant problems that may affect their ability to perform a reliable and reproducible test, as underweight children may have malnutrition that may affect their ability to perform the forced spirometric maneuver, whereas patients with acute exacerbation may have concomitant upper or lower respiratory infections and also they are usually put on inhalation therapy with inhaled bronchodilator that will alter the spirometric data. The aim and nature of the study was explained for each parent before inclusion and approval to participate in the study is mandatory. An informed written consent was obtained from parents / surrogates before enrollment. The study design conformed to the requirements of Revised Helsinki Declaration of Bioethics (2013). The study protocol was approved by the Scientific Research Committee of Pediatrics Department, Faculty of Medicine, Cairo University. For all children, the following were recorded; history taking [including age, gender, residence, history of wheezes, cough and shortness of breath, seasonal variation of symptoms, nocturnal symptoms, previous history of similar attacks, history of other atopic manifestations and family history of atopy], physical examination [including general examination (especially heart rate, respiratory rate, and temperature), chest examination: (inspection for shape of chest, respiratory movements and trachea, palpation for tenderness, trachea and chest movement), and auscultation for air entry, type of breathing and rhonchi)]. Assessment of control of asthma in our study depends on history from the parents about number and severity of the attacks and on pulmonary function tests, using GINA guidelines 1; being either controlled, partly controlled or uncontrolled asthmatics. Body mass index (BMI) was calculated (in kg/m2) for each participant. Accordingly, he/she was allocated to the appropriate subgroup. Spirometry was conducted at the pulmonary functions laboratory of Pediatric Allergy and Chest Unit of New Children's University Hospital using a pediatric spirometer (CareFusion Master Screen Paed®, Germany) according to American Thoracic Society (ATS) recommendations and reference values. A minimum of three forced expiratory maneuvers were performed at each session and the test result with best scores was included in the data analysis. Patients are asked to take a maximal inspiration and then to forcefully expel air for as long and as quickly as possible. Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), forced expiratory flow at 25 to 75% of vital capacity (FEF25-75) and peak flow rate (PFR) were measured and the FEV1/FVC ratio was calculated. The spirometry maneuvers were performed in random order in sitting and standing positions for each child with an interval of 15 minutes between the two positions. Changes of spirometric values in sitting and standing positions were calculated as follows: Percentage of change = [(first position - second position) / second position] × 100. This randomization of the order of tested positions aimed to reduce statistical bias of the results.

Statistical analysis

The SPSS software (Statistical Package for the Social Sciences, version 19.0, Inc, Chicago, Ill, USA) and Microsoft Excel software program were used to tabulate the results and represent them graphically. Quantitative variables were expressed as mean and standard deviation. Qualitative variables were expressed as count and percentage. The one-way analysis of variance was used to test the differences between groups. The Duncan multiple comparison test was used to test the significant differences between each pair of groups. The chi-square test was used to compare the distributions between groups. The Pearson correlation coefficient test used to test the significant correlations between the quantitative parameters within each group. A P value less than 0.05 is considered significant.

Results

Our study included 60 asthmatic children, 30 of them were males and 30 were females. Mean age of our patients was 9.70± 0.26 years, their mean weight was 34.75 ± 12.48 kg, their mean height was 133.60± 12.76 and their mean BMI was 19.06± 4.12 kg/m2. Patients were classified according to weight into 3 subgroups; subgroup 1: included asthmatic children with normal body weight [39 patients (65%)], subgroup 2: included overweight asthmatic children [14 patients (23.33%)] andubgroup 3: included obese asthmatic children [7 patients (11.67%)]. Twenty-seven patients (45%) were well controlled, 25 patients (41.67%) were partially controlled and 8 patients (13.33%) were not controlled. Table (1) shows the effect of position on % predicted spirometric data of all cases. There was no significant effect of position on spirometric data of all asthmatic children.
Table 1

Effect of position on % predicted spirometric data of all cases

Sitting positionStanding position95% CIP-value
FEV190.84 ± 28.1991.04 ± 27.06-10.20, 9.790.968
FVC85.97 ± 29.0587.50 ± 29.90-12.19, 9.120.776
FEV1/FVC106.77 ± 9.24105.78 ± 11.21-2.73, 4.700.599
FEF2588.03 ± 36.5390.96 ± 39.29-16.65, 10.790.673
FEF5082.46 ± 28.6784.38 ± 31.82-12.88, 9.030.728
FEF7579.96 ± 23.1380.73 ± 26.02-9.67, 8.130.864
PEF76.71 ± 24.2278.80 ± 26.42-11.26, 7.070.652

FEV1: forced expiratory volume in 1 second

FEV: forced expiratory volume

FVC: forced vital capacity

PEF: peak expiratory flow

FEF: Forced expiratory flow

PFR: peak flow rate

95% CI= Confidence intervals at 95% level

Effect of position on % predicted spirometric data of all cases FEV1: forced expiratory volume in 1 second FEV: forced expiratory volume FVC: forced vital capacity PEF: peak expiratory flow FEF: Forced expiratory flow PFR: peak flow rate 95% CI= Confidence intervals at 95% level Table (2) shows the effect of position on % predicted spirometric data of normal weight children (39 patients) and overweight/obese children (21 patients). There was no significant effect of position on spirometric data of normal weight asthmatic children. There was also no significant effect of position on spirometric data of overweight/obese asthmatic children.
Table 2

Effect of position on % predicted spirometric data of normal weight children (n=39) and overweight/obese children (n=21)

Sitting positionStanding position95% CIP-value
Normal weightFEV190.8 ± 33.290.1 ± 32.2-14.05, 15.430.926
FVC84.2 ± 33.485.2 ± 34.6-16.39, 14.300.892
FEV1/FVC108.71 ± 7.77107.11±8.69-2.12, 5.320.395
FEF2589.2 ± 36.293.7 ± 40.4-21.82,12.780.604
FEF5083.9 ± 32.2 -87.9 ± 33.818.91,10.890.594
FEF7580.6 ± 27.382.4 ± 25.4-13.75,10.070.759
PEF78.1 ± 28.580.6 ± 28.0-15.17, 10.320.706
Overweight/ ObeseFEV191.0 ± 16.092.8 ± 13.7-11.15, 7.410.686
FVC89.3 ± 18.991.7 ± 18.1-13.98, 9.110.672
FEV1/FVC103.2 ± 10.8103.3 ± 14.7-8.22, 7.940.971
FEF2585.8 ± 37.985.8 ± 37.6-23.5, 23.60.998
FEF5079.8 ± 21.177.9 ± 27.2-13.29, 17.180.798
FEF7578.9 ± 12.677.6 ± 27.4-12.28, 14.700.856
PEF74.1 ± 13.275.6 ± 23.5-13.47, 10.530.804

FEV1: forced expiratory volume in 1 second

FEV: forced expiratory volume

FVC: forced vital capacity

PEF: peak expiratory flow

FEF: Forced expiratory flow

PFR: peak flow rate

95% CI= Confidence intervals at 95% level

Effect of position on % predicted spirometric data of normal weight children (n=39) and overweight/obese children (n=21) FEV1: forced expiratory volume in 1 second FEV: forced expiratory volume FVC: forced vital capacity PEF: peak expiratory flow FEF: Forced expiratory flow PFR: peak flow rate 95% CI= Confidence intervals at 95% level Table (3) shows the effect of weight on sitting and standing % predicted spirometric values. Sitting FEV1/FVC was significantly lower in overweight/obese group compared to normal weight group (p value=0.046).
Table 3

Effect of weight on sitting and standing % predicted spirometric values

Normal weight (n=39)Overweight/obese (n=21)95% CIP- value
SittingFEV190.8 ± 33.291.0 ± 16.0-12.90, 12.540.977
FVC84.2 ± 33.489.3 ± 18.9-18.58, 8.440.455
FEV1/FVC108.71 ± 7.77103.2 ± 10.80.12, 10.970.046*
FEF2589.2 ± 36.285.8 ± 37.9-17.1, 23.80.741
FEF5083.9 ± 32.279.8 ± 21.1-9.83, 17.890.562
FEF7580.6 ± 27.378.9 ± 12.6-8.65, 12.050.744
PEF78.1 ± 28.574.1 ± 13.2-6.77, 14.850.457
StandingFEV190.1 ± 32.292.8 ± 13.7-14.68, 9.190.647
FVC85.2 ± 34.691.7 ± 18.1-20.10, 7.180.347
FEV1/FVC107.11 ± 8.69103.3 ± 14.7-3.39, 10.990.288
FEF2593.7 ± 40.485.8 ± 37.6-13.2, 29.00.453
FEF5087.9 ± 33.877.9 ± 27.2-6.18, 26.140.220
FEF7582.4 ± 25.477.6 ± 27.4-9.90, 19.400.516
PEF80.6 ± 28.075.6 ± 23.5-8.71, 18.700.467

FEV1: forced expiratory volume in 1 second FEV: forced expiratory volume FVC: forced vital capacity PEF: peak expiratory flow

FEF: Forced expiratory flow PFR: peak flow rate 95% CI= Confidence intervals at 95% level.

Effect of weight on sitting and standing % predicted spirometric values FEV1: forced expiratory volume in 1 second FEV: forced expiratory volume FVC: forced vital capacity PEF: peak expiratory flow FEF: Forced expiratory flow PFR: peak flow rate 95% CI= Confidence intervals at 95% level. However, there was no effect of weight on standing spirometric data of asthmatic children. Correlations between level of asthma control and other variables revealed that weight has significant negative correlation with asthma control level; as weight increases, asthma control worsens (r = -0.262, -0.385, respectively, p= 0.043, 0.002, respectively). However, there were no significant correlations between level of asthma control and age, height and BMI) (table 4).
Table 4

Correlations between level of asthma control and other variables (n=60)

VariablesResults
Asthma controlAge (yrs)r-0.056
p-value0.671
Weight (kg)r--0.262
p-value0.043*
Height (cm)r--0.173
p-value0.187
Body mass index (BMI)r--0.180
p-value0.168
Correlations between level of asthma control and other variables (n=60)

Discussion

The aim of this study was to evaluate the spirometric measurements in standing and sitting positions in a group of Egyptian asthmatic children with different body mass index (BMI). The present study hypothesized that pediatric spirometric values would be affected by the body weight as well as the position of the child during test conduction. Asthma is one of the most common chronic illnesses in the world, and reports in the Middle East suggest that the prevalence of asthma is increasing. Poor knowledge, fear of the use of new drugs, and the lack of awareness of the importance of disease control are common among primary care physicians who care for asthma patients. In addition to these important factors, there are other attributes to the magnitude of disease burdens such as socioeconomic status, number of siblings, knowledge of caregivers, and income11. Pulmonary function tests (PFTS) are important tools in the investigation and monitoring of patients with respiratory pathology. Spirometry is the most frequently used measurement of lung function and is a measurement of volume against time. It is a simple and quick procedure to perform5. The present study showed that there were no significant differences between standing and sitting positions on spirometric data of all asthmatic children. Similarly, Razi and Moosavi (2007)9 conducted a study on adult obese asthmatics and compared their spirometric values to normal weight asthmatics, and concluded that spirometric values in obese asthmatic patients with BMI ≥30 were not affected by the standing or sitting positions. On the contrary, Lalloo et al., (1991)12 examined the effect of the standing versus the sitting position on spirometric indices in 94 healthy non-obese adult subjects On average, all the spirometric indices examined, except the peak expiratory flow rate, were higher in the standing compared to the sitting position although the change was not significant except for FEV1 in women. In the current study, sitting FEV1/FVC was significantly lower in overweight/obese asthmatic children compared to normal weight asthmatic children. The lower expired volumes measured in the sitting position were probably due to the overweight/obese children are taking slightly smaller inspirations in sitting posture than in the standing position. These results appear to be different from the findings of Berntsen et al., (2011)4, done for children and adolescents (23 overweight and 92 obese) children (7–17 years old), performed forced expiratory flow-volume manoeuvres in sitting and standing posture in random order, and concluded that FEV1, FVC and FEF50 were significantly higher in sitting compared with standing posture. FEV1/FVC and peak expiratory flow were not significantly different measured in sitting and standing posture. However, there were significant design differences between the two works as Berntsen and his colleagues examined overweight and obese children where only 15% of them were asthmatics, and the rest were not having bronchial asthma, and they did not include normal weight children. Razi and Moosavi (2007)9 included 49 obese asthmatic patients with mean age of 42.63 years and BMI of 36.06 kg/m2, and 51 control obese normal that spirometric values in obese asthmatic patients with BMI ≥30 were not affected by the standing and sitting positions. The present study declared that weight was significantly inversely correlated with asthma control level. This conclusion was supported by Wang and Pan (2016) 13 who investigated the effects of obesity on response to therapy and pulmonary function in children with asthma. A total of 129 children with asthma; normal weight group (n=64) and obese group (n=65) and 68 healthy children (control group). They found that there were significant differences in the indices of pulmonary function between the three groups before treatment (P<0.01); the healthy control group had the best values of pulmonary function, while the obese group had the worst values. After 1 year of treatment, the normal weight group showed significantly more improvements in FEV1% and FVC% than the obese group (P<0.01). The normal weight group had a significantly better asthma control status than the obese group (P<0.01). Spathopoulos et al., (2009)14 aimed to investigate the effect of obesity on pulmonary function tests and secondary the possible link of obesity with atopy and asthma in a large cohort of children (2,715 children aged 6–11 years). Six hundred fifty seven children with BMI > 85th percentile (357 overweight, 300 obese) and a group of 196 normal weight children underwent spirometry. The % expected FVC, FEV1, FEF25-75, and FEV1/FVC were significantly reduced in overweight or obese children compared to children with normal weight (P = 0.007, P < 0.001, P < 0.001, and P < 0.001, respectively). On the other hand, Andrade et al., (2013)15 investigated obesity and asthma by comparing gender, age, initial classification of asthma, clinical control, basal forced FEV1and FEF25-75 with rates of BMI in asthmatic adolescents. The study involved 120 asthmatics patients (1.9 male: 1 female) with a mean age of 14.1 years (9 to 20.1 years of age). They found no significant correlations were found between BMI and FEV1 and between BMI and FEF25-75. They reported that no significant correlation was found between overweight/obesity and asthma using clinical, anthropometric, and spirometric parameters. The current small study was one of the few works addressing the issue of position and weight on spirometric values of asthmatic children. However, it had its share of limitations; for example, the small sample size, the lack of follow-up, and the small number of children in the obese subgroup. However, authors believe that this might serve as a preliminary report upon which further studies on a larger scale can be conducted in the future. We did not add control group of normal children as this will make the aim of the work is to study the effects of asthma on pulmonary function tests (PFTS) and this was well-studied before in the literature. We are concerned with the effects of overweight in asthmatic children, on PFT, which is not investigated enough in the literature.

Conclusion

There is no significant difference between standing and sitting positions on spirometric data of asthmatic children. Sitting FEV1/FVC is significantly lower in overweight/obese asthmatic children compared to normal weight asthmatic children. Weight significantly inversely correlated with asthma control level. The study recommends conduction of further studies on the effect of posture and overweight and obesity on spirometric results of asthmatic children on a larger number of cases.
  14 in total

1.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

2.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003.

Authors:  Leonardo Fabbri; Romain A Pauwels; Suzanne S Hurd
Journal:  COPD       Date:  2004-04       Impact factor: 2.409

3.  [Impact of obesity on response to therapy and pulmonary function in children with asthma].

Authors:  Jing Wang; Jia-Hua Pan
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-01

4.  Effects of posture on lung function in obese children.

Authors:  Sveinung Berntsen; Elisabeth Edvardsen; Kai-Håkon Carlsen; Magnhild Louise Pollestad Kolsgaard; Karin Cecilie Lødrup Carlsen
Journal:  Clin Respir J       Date:  2010-11-10       Impact factor: 2.570

5.  Obesity and asthma: association or epiphenomenon?

Authors:  Larissa Smiljanic Andrade; Andrea Cristina T B Araújo; Tatiana Moraes Cauduro; Letícia Aki Watanabe; Ana Paula B M Castro; Cristina Miuki A Jacob; Antonio Carlos Pastorino
Journal:  Rev Paul Pediatr       Date:  2013-06

6.  The effect of positions on spirometric values in obese asthmatic patients.

Authors:  Ebrahim Razi; Gholam Abbass Moosavi
Journal:  Iran J Allergy Asthma Immunol       Date:  2007-09       Impact factor: 1.464

7.  The effect of obesity on pulmonary lung function of school aged children in Greece.

Authors:  Diogenis Spathopoulos; Emmanouil Paraskakis; Grigorios Trypsianis; Aggelos Tsalkidis; Vasiliki Arvanitidou; Maria Emporiadou; Demosthenes Bouros; Athanasios Chatzimichael
Journal:  Pediatr Pulmonol       Date:  2009-03

8.  Effect of standing versus sitting position on spirometric indices in healthy subjects.

Authors:  U G Lalloo; M R Becklake; C M Goldsmith
Journal:  Respiration       Date:  1991       Impact factor: 3.580

9.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06

10.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

Authors:  Kian Fan Chung; Sally E Wenzel; Jan L Brozek; Andrew Bush; Mario Castro; Peter J Sterk; Ian M Adcock; Eric D Bateman; Elisabeth H Bel; Eugene R Bleecker; Louis-Philippe Boulet; Christopher Brightling; Pascal Chanez; Sven-Erik Dahlen; Ratko Djukanovic; Urs Frey; Mina Gaga; Peter Gibson; Qutayba Hamid; Nizar N Jajour; Thais Mauad; Ronald L Sorkness; W Gerald Teague
Journal:  Eur Respir J       Date:  2013-12-12       Impact factor: 16.671

View more
  2 in total

1.  Association between obesity and lung function in South African adolescents of African Ancestry.

Authors:  Godwill Azeh Engwa; Chungag Anye; Benedicta Ngwenchi Nkeh-Chungag
Journal:  BMC Pediatr       Date:  2022-02-28       Impact factor: 2.125

2.  Comparison of Pulmonary Function and Inflammation in Children/Adolescents with New-Onset Asthma with Different Adiposity Statuses.

Authors:  Xiaolan Ying; Jie Lin; Shuhua Yuan; Chunhong Pan; Wenfang Dong; Jing Zhang; Lei Zhang; Jilei Lin; Yong Yin; Jinhong Wu
Journal:  Nutrients       Date:  2022-07-20       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.